GRAIL Inc. Stock Analysis & AI Score
GRAIL Inc. (GRAL) has an ST Score of 47.0 (C+), driven by its Financial Strength (A+) and held back by its Profitability (F). Analysts rate it Buy with a $83.67 price target (-33.2% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
GRAIL Inc. (GRAL) has an ST Score of 47.0 (C+), driven by its Financial Strength (A+) and held back by its Profitability (F). Analysts rate it Buy with a $83.67 price target (-33.2% downside).
- Strongest
- Financial StrengthA+
- Weakest
- ProfitabilityF
All factor grades
- Financial StrengthA+
- MomentumA-
- ValuationB+
- ForecastC-
- GrowthD
- ProfitabilityF
- Piotroski4/9
Contact
GRAL stock: frequently asked questions
What is GRAL's ST Score?
GRAIL Inc. (GRAL) has an ST Score of 47.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GRAL a buy, hold, or sell?
Analysts rate GRAL a Buy, with a price target of $83.67 (-33.2% vs the current price). Our ST Score grades it C+ (47.0/100). The ST Score is a data-driven signal, not a recommendation.
What are GRAL's factor grades?
Valuation B+, Profitability F, Financial Strength A+, Momentum A-, Growth D, Forecast C-.
What is GRAL's valuation grade?
GRAIL Inc. (GRAL) earns a valuation grade of B+, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GRAL's growth grade?
GRAIL Inc. (GRAL) earns a growth grade of D, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GRAL's profitability grade?
GRAIL Inc. (GRAL) earns a profitability grade of F, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GRAL's financial strength grade?
GRAIL Inc. (GRAL) earns a financial strength grade of A+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GRAL?
The average analyst price target for GRAIL Inc. (GRAL) is $83.67 from 7 analysts, which is -33.2% versus the recent price of $125.21.
What is GRAL's Piotroski score?
GRAIL Inc. (GRAL) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.